The STOPBAG2 scoring instrument, which incorporates sleep-related symptoms and continuous variables for age and BMI, offers greater discriminatory power for predicting all levels of OSA severity in adults with epilepsy.
Add-on cannabidiol was found to be safe and effective for patients with Lennox Gastaut Syndrome.
Researchers find that many Huntington disease specialist clinics do not have the resources available to administer DMTs appropriately with an intrathecal strategy.
Investigators have identified a novel genetic association for tau deposition, with resistance to entorhinal cortex (ERC) deposition, in older adults.
In patients with SMA, treatment with nusinersen was associated with improvement in health-related quality of life and reduced impact on caregivers.
Youth with a history of status migranosus are more likely to experience an increase of >4 headache days per month during a follow-up evaluation.
Certain components of metabolic syndrome may be more common in patients with Parkinson disease who are carriers of an LRRK2 mutation compared with other PD etiologies.
Prolonged delays from ICH symptom onset to hospital presentation is associated with worse functional outcomes at 3 months, compared with earlier presentation.
Researchers sought to validate traumatic encephalopathy syndrome criteria for the diagnosis and management of patients with CTE.
Treatment with fremanezumab for episodic and chronic migraine was found to have a favorable cardiovascular safety profile in patients with and without a history of cardiovascular disease.
